An Individualized Approach to Major Depressive Disorder: The Pharmacist's Role
This activity reviews how to differentiate and treat MDD with newly incorporated “specifiers” that contribute to a more complex clinical presentation and course of illness.
Examining Major Depressive Disorder: Emerging Therapies and the Potential Beyond Monoaminergic Pathways
An estimated that 16.2 million Americans have had one major depressive episode in 2016. This educational activity aims to examine the neurobiology of major depressive orders.
Suicide Prevention: Pharmacist Engagement in Reducing the Risk (Pharmacist Technicians)
Upon completion of this activity, participants will be able to improve access to care by referring patients to resources for the management of suicidality.
Suicide Prevention: Pharmacist Engagement in Reducing the Risk (Pharmacists)
Upon completion of this activity, participants will be able to assess suicide risk, including identification of risk factors for and signs of suicidality.